GRAND JUNCTION, Colo., Feb. 26, 2024 (GLOBE NEWSWIRE) — ProStar Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), a world leader in Precision Mapping Solutions, is pleased to announce a technology… Read More »ProStar and Topcon Announce Technology Integration with PointMan
Trust Stamp received a notice of allowance from the US Patent and Trademark Office for a new patent covering facial recognition where the subjects face is significantly obscured by a mask or other covering Atlanta,… Read More »Trust Stamp Announces the Continued Growth of its Patent Portfolio Encompassing AI-Powered Identity Solutions
Porter joined Pelion Venture Partners and others to discuss SBIC reforms and new partnerships to invest in critical technologies vital to national security AMERICAN FORK, Utah, Feb. 26, 2024 (GLOBE NEWSWIRE) — LiveView Technologies (LVT)… Read More »LiveView Technologies Founder and CEO Ryan Porter Discusses Small Business Support at White House
Joint Venture Company to develop Large Language Models (LLM) specifically for telecommunications companies Joint Venture Company to be established within this year Initial fine-tuning of models takes place BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/… Read More »SKT, Deutsche Telekom, e&, Singtel, and SoftBank Corp. Announce Plan to Establish a Joint Venture
BARCELONA, Spain, Feb. 26, 2024 /PRNewswire/ — Innovative technology brand TECNO officially announced its groundbreaking multi-skin tone color card at MWC Barcelona 2024. The multi-skin tone color card sets a new benchmark for multi-skin… Read More »TECNO Unveils its Industry Bench-marking Multi-Skin Tone Color Card at MWC Barcelona 2024, Marking a Major Step-Forward in Mobile Portrait Inclusivity
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of promising immuno-oncology candidates – BRYAN, Texas and SAN DIEGO, Feb. 26, 2024… Read More »iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka